ADVB
Advanced Biomed, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$2.10
−4.55%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 4.49x
- PEG TTM
- —
- Price / book
- 0.28x
- Price / sales
- 27.18x
- Price / cash flow
- -2.85x
Enterprise value
- Enterprise value
- $3.7M
- EV / sales
- 28.92x
- EV / EBITDA
- -0.57x
- EV / EBIT
- -0.58x
- Market cap
- $3.5M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026